Sutter Health   Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Sacramento CA United States (1921)

Organization Overview

First Clinical Trial
2008
NCT00631852
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Nisha Acharya | Sonoma West Medical Center, Santa Rosa Memorial Hospital, Sutter Health | Sutter Gould Medical Foundation | Sutter Health

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acute Coronary Syndrome (Phase 4)

Alzheimer Disease (Phase 2)

Anemia, Iron-Deficiency (Phase 4)

Autism Spectrum Disorder (Phase 1)

Autistic Disorder (Phase 2)

Blepharoptosis (Phase 3)

Breast Neoplasms (Phase 2)

Carcinoma (Phase 3)

Cognitive Dysfunction (Phase 2)

Compartment Syndromes (Phase 3)

Esotropia (Phase 3)

Exotropia (Phase 3)

Fractures, Bone (Phase 4)

Fractures, Stress (Phase 4)

Glioblastoma (Phase 1)

Graves Disease (Phase 3)

Heart Failure (Phase 4)

Leukemia, Myeloid, Acute (Phase 2)

Myelodysplastic Syndromes (Phase 2)

Nasopharyngeal Carcinoma (Phase 3)

Penile Induration (Phase 4)

Recurrence (Phase 4)

Strabismus (Phase 3)

Syndrome (Phase 3)

Triple Negative Breast Neoplasms (Phase 2)

Uveitis (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 11
  • # of Trial APIs: 11